These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 562238)
21. Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide. Wahl SM; Wahl LM; McCarthy JB; Chedid L; Mergenhagen SE J Immunol; 1979 Jun; 122(6):2226-31. PubMed ID: 221582 [TBL] [Abstract][Full Text] [Related]
22. Further study on relationship of anti-tuberculous protection to lung granulomata produced by intravenous injections of synthetic 6-0-mycoloyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with or without specific antigens. Yamamoto K; Kato K; Kakinuma M; Okuyama H; Azuma I Immunology; 1982 Jun; 46(2):473-9. PubMed ID: 7044961 [TBL] [Abstract][Full Text] [Related]
23. Influence of MDP and of some analogous synthetic glycopeptides on the in vitro mouse spleen cell viability and immune response to sheep erythrocytes. Leclerc C; Löwy I; Chedid L Cell Immunol; 1978 Jul; 38(2):286-93. PubMed ID: 567100 [No Abstract] [Full Text] [Related]
24. Dissociation of immunostimulant activities of muramyl dipeptide (MDP) by linking amino-acids or peptides to the glutaminyl residue. Audibert F; Parant M; Damais C; Lefrancier P; Derrien M; Choay J; Chedid L Biochem Biophys Res Commun; 1980 Sep; 96(2):915-23. PubMed ID: 7426019 [No Abstract] [Full Text] [Related]
25. Control of the mitogenicity of muramyl dipeptide. Wood DD; Staruch MJ Int J Immunopharmacol; 1981; 3(1):31-44. PubMed ID: 6975247 [No Abstract] [Full Text] [Related]
26. The effect of 2-mercaptoethanol on murine mixed lymphocyte cultures. Bevan MJ; Epstein R; Cohn M J Exp Med; 1974 Apr; 139(4):1025-30. PubMed ID: 4816300 [TBL] [Abstract][Full Text] [Related]
27. [Effect of novel derivatives of muramyl dipeptide on the immune system]. Kaliuzhin OV; Fuks BB; Bovin NV; Zemliakov AE; Chirva VIa Biull Eksp Biol Med; 1994 May; 117(5):510-3. PubMed ID: 9296705 [No Abstract] [Full Text] [Related]
28. In vitro stimulation of murine spleen cells using a microculture system and a multiple automated sample harvester. Strong DM; Ahmed AA; Thurman GB; Sell KW J Immunol Methods; 1973 Apr; 2(3):279-91. PubMed ID: 4695475 [No Abstract] [Full Text] [Related]
29. Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs. Chedid L; Parant M; Parant F; Lefrancher P; Choay J; Lederer E Proc Natl Acad Sci U S A; 1977 May; 74(5):2089-93. PubMed ID: 325566 [TBL] [Abstract][Full Text] [Related]
30. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response. Lowy I; Theze J; Chedid L J Immunol; 1980 Jan; 124(1):100-4. PubMed ID: 6965289 [TBL] [Abstract][Full Text] [Related]
31. [Immunostimulating effects of muramyl dipeptide, glucosaminyl muramyl dipeptide and their synthetic derivatives in vitro]. Rakhmilevich AL; Rakhimova MS; Andronova TM; Bovin NV Antibiot Khimioter; 1989 Aug; 34(8):586-9. PubMed ID: 2589897 [TBL] [Abstract][Full Text] [Related]
32. Nonspecific activation of murine lymphocytes. IV. Proliferation of a distinct, late maturing lymphocyte subpopulation induced by 2-mercaptoethanol. Goodman MG; Fidler JM; Weigle WO J Immunol; 1978 Nov; 121(5):1905-13. PubMed ID: 712070 [No Abstract] [Full Text] [Related]
33. Enhancement of carrier-specific helper T cell function by the synthetic adjuvant, N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP). Sugimoto M; Germain RN; Chedid L; Benacerraf B J Immunol; 1978 Mar; 120(3):980-2. PubMed ID: 344799 [TBL] [Abstract][Full Text] [Related]
35. Adjuvant activity of 6-O-mycoloyl-N-acetylmuramuyl-L-alanyl-D-isoglutamine. Yamamura Y; Azuma I; Sugimura K; Yamawaki M; Uemiya M Gan; 1976 Dec; 67(6):867-77. PubMed ID: 828599 [TBL] [Abstract][Full Text] [Related]
36. [Inhibition of IgE antibody formation by tubercle bacilli and muramyl peptide]. Kishimoto T Kekkaku; 1980 Oct; 55(10):467-70. PubMed ID: 6785511 [No Abstract] [Full Text] [Related]
37. Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan. Chang YH; Pearson CM; Chedid L J Exp Med; 1981 Apr; 153(4):1021-6. PubMed ID: 6972989 [TBL] [Abstract][Full Text] [Related]
38. Study of immunomodulatory properties of N-acetylmuramyl-L-alanyl-D-isoglutamine and N-acetylglucosaminyl-(beta 1----4)-N-acetylmuramyl-L-alanyl-D-isoglutamine. Dozmorov IM; Kuzin II; Lutsan NI; Lutsenko GV; Prokhorova AL; Sapozhnikov AM; Andronova TM; Ivanov VT Biomed Sci; 1991; 2(6):651-8. PubMed ID: 1841635 [TBL] [Abstract][Full Text] [Related]
39. The adjuvant activity of synthetic N-acetylmuramyl-dipeptide: evidence of initial target cells for the adjuvant activity. Sugimura K; Uemiya M; Saiki I; Azuma I; Yamamura Y Cell Immunol; 1979 Mar; 43(1):137-49. PubMed ID: 313841 [No Abstract] [Full Text] [Related]
40. Target cells for the activity of a synthetic adjuvant: muramyl dipeptide. Löwy I; Bona C; Chedid L Cell Immunol; 1977 Mar; 29(1):195-9. PubMed ID: 321136 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]